RE-BVS – Piemonte Repository

Sfoglia per AUTORE
FOA R
Collezione AO Ordine Mauriziano

Items : 9

Outcome of 421 adult patients with Philadelphia-negative acute lymphoblastic leukemia treated under an intensive program inspired by the GIMEMA LAL1913 clinical trial: a Campus ALL study. in Haematologica / Haematologica. 2025 Jan 1;110(1):55-67. doi: 10.3324/haematol.2024.285638.

2025
AO Ordine Mauriziano

Lazzarotto D; Cerrano M; Papayannidis C; Chiaretti S; Mosna F; Fracchiolla N; Zappasodi P; Imbergamo S; Del Principe MI; Lunghi M; Lussana F; Piccini M; Fumagalli M; Dargenio M; Salutari P; Forghieri F; Da Molin TG; Bonifacio M; Olivi M; Giglio F; Trappolini S; Leoncin M; Mule A; Delia M; Pasciolla C; Grimaldi F; Cambo B; Santoro L; Guolo F; et alii...

Blinatumomab differentially modulates peripheral blood and bone marrow immune cell repertoire: A Campus ALL study. in British journal of haematology / Br J Haematol. 2023 Nov;203(4):637-650. doi: 10.1111/bjh.19104. Epub 2023 Sep 12.

2023
AO Ordine Mauriziano

Ocadlikova D; Lussana F; Fracchiolla N; Bonifacio M; Santoro L; Delia M; Chiaretti S; Pasciolla C; Cignetti A; Forghieri F; Grimaldi F; Corradi G; Zannoni L; De Propris S; Borleri GM; Tanasi I; Vadakekolathu J; Rutella S; Guarini AR; Foà R; Curti A;

High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 - VERITAS study. in Haematologica / Haematologica. 2023 Aug 1;108(8):2091-2100. doi: 10.3324/haematol.2022.282116.

2023
AOU Alessandria
AO Cuneo
AO Ordine Mauriziano

Foà R; Fazi P; Vignetti M; Piciocchi A; Cuneo A; Del Giudice I; Guarini A; De Propris MS; Nanni M; De Novi LA; Neri A; Albano F; Vitale C; Visentin A; Mattiello V; Pietrasanta D; Molinari MC; Giordano A; Gottardi D; Liberati AM; Patrizi VB; Deodato M; Galieni P; Arcari A; Musuraca G; Levato L; Tani M; Marchetti M; Rigolin GM; et alii...

Treatment-free remission in chronic myeloid leukemia patients treated front-line with nilotinib: 10-year followup of the GIMEMA CML 0307 study. in Haematologica / Haematologica. 2022 Oct 1;107(10):2356-2364. doi: 10.3324/haematol.2021.280175.

2022
AO Ordine Mauriziano

Gugliotta G; Castagnetti F; Breccia M; Levato L; Intermesoli T; D'Adda M; Salvucci M; Stagno F; Rege-Cambrin G; Tiribelli M; Martino B; Bocchia M; Cedrone M; Trabacchi E; Cavazzini F; Porretto F; Sorà F; Simula MP; Albano F; Soverini S; Foà R; Pane F; Cavo M; Saglio G; Baccarani M; Rosti G;

Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report. in Hematological oncology / Hematol Oncol. 2021 Oct;39(4):570-574. doi: 10.1002/hon.2899. Epub 2021 Jul 13.

2021
AOU Alessandria
AO Cuneo
AO Ordine Mauriziano

Chiarenza A; Orsucci L; Levato L; Gottardi D; Derenzini E; Gattei V; Sanna A; Gozzetti A; Baratè C; Olivieri J; Murru R; Gentile M; Leone M; Stefoni V; Malerba L; Ibatici A; Tisi MC; Marasca R; Chiurazzi F; Del Poeta G; Varettoni M; Farina L; Giordano A; Marchetti M; De Paoli L; Foglietta M; Re F; Ferrari A; Pietrasanta D; et alii...

Efficacy of Front-Line Ibrutinib and Rituximab Combination and the Impact of Treatment Discontinuation in Unfit Patients with Chronic Lymphocytic Leukemia: Results of the Gimema LLC1114 Study. in Cancers / Cancers (Basel). 2021 Dec 31;14(1):207. doi: 10.3390/cancers14010207.

2021
AOU Alessandria
AO Ordine Mauriziano

Piciocchi A; Guarini A; Rigolin GM; Neri A; Fazi P; Nanni M; Raponi S; Della Starza I; De Propris MS; Del Giudice I; Ruocco V; Murru R; Laurenti L; Varettoni M; Ibatici A; Chiarenza A; Gentile M; Molinari A; Gozzetti A; Zinzani PL; Musuraca G; Gottardi D; Tani M; Re F; Liberati AM; Orsucci L; Ilariucci F; Di Renzo N; Stelitano C; et alii...

Tailoring CD19xCD3-DART exposure enhances T-cells to eradication of B-cell neoplasms. in Oncoimmunology / Oncoimmunology. 2018 Feb 8;7(4):e1341032. doi: 10.1080/2162402X.2017.1341032. eCollection 2018.

2018
AO Ordine Mauriziano

Circosta P; Elia AR; Landra I; Machiorlatti R; Todaro M; Aliberti S; Brusa D; Deaglio S; Chiaretti S; Bruna R; Gottardi D; Massaia M; Giacomo FD; Guarini AR; Foà R; Kyriakides PW; Bareja R; Elemento O; Chichili GR; Monteleone E; Moore PA; Johnson S; Bonvini E; Cignetti A; Inghirami G;

Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: correlation with biologically-based risk stratification. in Haematologica / Haematologica. 2017 Sep;102(9):e352-e355. doi: 10.3324/haematol.2016.156901. Epub 2017 Jun 8.

2017
AO Ordine Mauriziano

Laurenti L; Innocenti I; Autore F; Ciolli S; Mauro FR; Mannina D; Del Poeta G; D'Arena G; Massaia M; Coscia M; Molica S; Pozzato G; Efremov DG; Vannata B; Marasca R; Galieni P; Cuneo A; Orlando S; Piciocchi A; Boncompagni R; Vincelli D; Liberati AM; Russo F; Foá R;

Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia. in Blood / Blood. 2015 Oct 15;126(16):1921-4. doi: 10.1182/blood-2015-05-647925. Epub 2015 Aug 14.

2015
AO Ordine Mauriziano

Rossi D; Terzi-di-Bergamo L; De Paoli L; Cerri M; Ghilardi G; Chiarenza A; Bulian P; Visco C; Mauro FR; Morabito F; Cortelezzi A; Zaja F; Forconi F; Laurenti L; Del Giudice I; Gentile M; Vincelli I; Motta M; Coscia M; Rigolin GM; Tedeschi A; Neri A; Marasca R; Perbellini O; Moreno C; Del Poeta G; Massaia M; Zinzani PL; Montillo M; et alii...